Carregant...
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Aberrantly glycosylated mucin 1 (MUC1) is a recognized tumor-specific antigen on epithelial cell tumors. A wide variety of MUC1 glycopeptide anti-cancer vaccines have been formulated by many research groups. Some researchers have used MUC1 alone as an immunogen whereas other groups used different an...
Guardat en:
| Publicat a: | Vaccines (Basel) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5041019/ https://ncbi.nlm.nih.gov/pubmed/27472370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines4030025 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|